- Home
- Publications
- Publication Search
- Publication Details
Title
Contemporary Management of Localized Resectable Pancreatic Cancer
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 1, Pages 24
Publisher
MDPI AG
Online
2018-01-22
DOI
10.3390/cancers10010024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
- (2017) Marianne Sinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy
- (2017) Michael D. Kluger et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Current and future therapies for advanced pancreatic cancer
- (2017) Rohan Gupta et al. JOURNAL OF SURGICAL ONCOLOGY
- Trends in Neoadjuvant Approaches in Pancreatic Cancer
- (2017) Lingling Du et al. Journal of the National Comprehensive Cancer Network
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study
- (2017) Ijin Joo et al. RADIOLOGY
- Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
- (2017) Marco Del Chiaro et al. JAMA Surgery
- Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
- (2016) Steffi J. Rombouts et al. ANNALS OF SURGICAL ONCOLOGY
- Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags
- (2016) Kazuyuki Sogawa et al. BRITISH JOURNAL OF CANCER
- Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer
- (2016) W. Hartwig et al. BRITISH JOURNAL OF SURGERY
- Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Edward P. Balaban et al. JOURNAL OF CLINICAL ONCOLOGY
- Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma
- (2016) Pavel Markov et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement
- (2016) J. Perinel et al. LANGENBECKS ARCHIVES OF SURGERY
- Clinical Effect of Surgical Volume
- (2016) Andrea L. Merrill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
- (2016) Matthew H. G. Katz et al. JAMA Surgery
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
- (2015) Eric A. Mellon et al. ACTA ONCOLOGICA
- The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience
- (2015) Shalini Moningi et al. ANNALS OF SURGICAL ONCOLOGY
- Pathology reporting of pancreatic cancer following neoadjuvant therapy: Challenges and uncertainties
- (2015) C. Verbeke et al. CANCER TREATMENT REVIEWS
- PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer
- (2015) Richard Kim et al. CLINICAL NUCLEAR MEDICINE
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Current State of Vascular Resections in Pancreatic Cancer Surgery
- (2015) Thilo Hackert et al. Gastroenterology Research and Practice
- Management of borderline resectable pancreatic cancer
- (2015) Amit Mahipal et al. World Journal of Gastrointestinal Oncology
- Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases
- (2015) Karsten Beiderwellen et al. PLoS One
- The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma
- (2014) Wenchuan Wu et al. ANNALS OF SURGICAL ONCOLOGY
- Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
- (2014) Juan W. Valle et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Neoadjuvant Therapy in the Multimodality Treatment of Older Patients with Pancreatic Cancer
- (2014) Amanda B. Cooper et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer
- (2014) Henriette Golcher et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer
- (2013) Hidenori Takahashi et al. ANNALS OF SURGERY
- Hospital Volume and Operative Mortality in the Modern Era
- (2013) Bradley N. Reames et al. ANNALS OF SURGERY
- A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
- (2013) Eileen M. OʼReilly et al. ANNALS OF SURGERY
- Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
- (2013) Fuyuhiko Motoi et al. ANNALS OF SURGICAL ONCOLOGY
- A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
- (2013) Edward J. Kim et al. CANCER
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis
- (2013) Wei-Chih Liao et al. LANCET ONCOLOGY
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
- (2013) Ching-Wei D. Tzeng et al. HPB
- Locally Advanced Pancreatic Cancer
- (2013) Brian E. Kadera et al. JAMA Surgery
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Is there a ‘margin’ for error in pancreatic cancer surgery?
- (2012) Adam E Frampton et al. Future Oncology
- Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
- (2012) Natalie Cook et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
- (2012) Masayuki Sho et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
- (2012) Katia T. Papalezova et al. JOURNAL OF SURGICAL ONCOLOGY
- New biomarkers and targets in pancreatic cancer and their application to treatment
- (2012) Eithne Costello et al. Nature Reviews Gastroenterology & Hepatology
- Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma
- (2012) Jae-Lyun Lee et al. SURGERY
- Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
- (2011) Jayme B. Stokes et al. ANNALS OF SURGICAL ONCOLOGY
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma
- (2010) Nigel B. Jamieson et al. ANNALS OF SURGERY
- Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
- (2010) Charles C. Hsu et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma
- (2010) Avo Artinyan et al. CANCER
- Plectin-1 as a Novel Biomarker for Pancreatic Cancer
- (2010) D. Bausch et al. CLINICAL CANCER RESEARCH
- Change in CA 19-9 Levels after Chemoradiotherapy Predicts Survival in Patients with Locally Advanced Unresectable Pancreatic Cancer
- (2010) G. Yang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections
- (2010) Anna Melissa Schlitter et al. Cancers
- Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
- (2009) Fiona Campbell et al. HISTOPATHOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
- (2008) Michele M. Corsini et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
- (2008) Joseph M. Herman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Hospital Volume on Margin Status after Pancreaticoduodenectomy for Cancer
- (2008) Karl Y. Bilimoria et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
- (2008) Viviane Hess et al. LANCET ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started